Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors
Future Medicinal Chemistry · 02.11.2026 · 18 (21) · 3013-3031
DOI: 10.1080/17568919.2026.2748643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 16.10.2026. Verfasst von Ayşen Işık und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Selçuk University, Konya, Turkey. Hauptthemen laut MEDLINE: Benzimidazoles, Aromatase Inhibitors, Antineoplastic Agents, Aromatase. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Selçuk University Scientific Research Projects.
Abstract (Originalsprache)
AIMS: A new series of benzimidazole derivatives (4a-4p) was designed, synthesized, and evaluated as potential aromatase inhibitors with anticancer activity. MATERIALS AND METHODS: The anticancer effects of the compounds were evaluated using the MCF-7 cell line. Derivatives that showed activity were subjected to an aromatase inhibition assay. Molecular docking, molecular dynamics simulations, and in silico ADMET profiling were performed for the selected compounds. RESULTS: Among the series, para-substituted derivatives 4d (Cl), 4h (OC2H5), and 4k (F) exhibited potent antiproliferative activity with low‑micromolar IC50 values (2.40-2.64 µM), surpassing cisplatin, while maintaining favorable selectivity profiles. CONCLUSIONS: This experimental and computational study identifies 4d as a promising lead for further development as a non-steroidal aromatase inhibitor for breast cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, Selçuk University, Konya, Turkey.
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- Hemp Research Institute, Yozgat Bozok University, Yozgat, Turkey.
- Department of Pharmacy, Vocational School of Health Services, Bilecik Seyh Edebali University, Bilecik, Turkiye.
- Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, İstinye University, Istanbul, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
ORCID-Profile: Ayşen Işık, Nour El-Huda Daoud, Kezban Uçar Çiftçi, Gulsah Congur, Ebru Nur Ay, Emine Rana Bagcı, Şennur Görgülü, Ulviye Acar Çevik, Yusuf Tutar, Yusuf Özkay, Zafer Asım Kaplancıklı
Förderung
- Selçuk University Scientific Research Projects
Zitieren
APA
Işık, A., Daoud, N. E., Uçar Çiftçi, K., Congur, G., Ay, E. N., Bagcı, E. R., Görgülü, Ş., Çevik, U. A., Tutar, Y., Özkay, Y., & Kaplancıklı, Z. A. (2026). Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors. Future Medicinal Chemistry, 18(21), 3013-3031. https://doi.org/10.1080/17568919.2026.2748643
Vancouver
Işık A, Daoud NE, Uçar Çiftçi K, Congur G, Ay EN, Bagcı ER, et al. Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors. Future Medicinal Chemistry. 2026;18(21):3013-3031. doi:10.1080/17568919.2026.2748643
BibTeX
@article{Ik2026,
author = {Işık, Ayşen and Daoud, Nour El-Huda and Uçar Çiftçi, Kezban and Congur, Gulsah and Ay, Ebru Nur and Bagcı, Emine Rana and Görgülü, Şennur and Çevik, Ulviye Acar and Tutar, Yusuf and Özkay, Yusuf and Kaplancıklı, Zafer Asım},
title = {Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {21},
pages = {3013--3031},
doi = {10.1080/17568919.2026.2748643}
}
EUVIMED